1.Effect of Acute Rehabilitation Treatment for Patients with Severe COVID-19
Keisuke HIROTA ; Shunji KOYA ; Tatsuya FUKUSHIMA ; Takahiro SUGIMOTO ; Hiroo MATSUSE ; Ryuki HASHIDA ; Souhei IWANAGA ; Masanobu MATSUOKA ; Osamu TAKASU ; Tomoaki HOSHINO ; Naoto SHIBA
The Japanese Journal of Rehabilitation Medicine 2022;59(10):1045-1055
Patients with severe coronavirus disease 2019 (COVID-19) have poor prognosis, with many cases being difficult to treat and many reports of neurological complications in patients who have been in the intensive care unit for a long time. Rehabilitation of patients with severe COVID-19 is important;however, no rehabilitation program has shown effectiveness. Thus, this study aimed to investigate the effects of a rehabilitation program developed and used at our hospital for patients with severe COVID-19. We enrolled 28 patients with severe COVID-19 (age 61[23-88]years;female/male, 9/19, body mass index, 25.0[18.0-33.6]kg/m2). We assessed the medical research council scoring (MRC) of the patients at the time of entry and exit from the ordinary ward using Wilcoxon signed-rank tests. MRC was significantly improved after exiting the ordinary ward compared with that on entering the ordinary ward (43 vs. 50 points;P<.001). Moreover, Barthel index improved significantly after exiting the ordinary (32.5 vs. 77.5 points, P<.001). Therefore, our acute rehabilitation treatment for patients with severe COVID-19 may be effective in improving their muscle strength and daily living.
2.Effect of Acute Rehabilitation Treatment for Patients with Severe COVID-19
Keisuke HIROTA ; Shunji KOYA ; Tatsuya FUKUSHIMA ; Takahiro SUGIMOTO ; Hiroo MATSUSE ; Ryuki HASHIDA ; Souhei IWANAGA ; Masanobu MATSUOKA ; Osamu TAKASU ; Tomoaki HOSHINO ; Naoto SHIBA
The Japanese Journal of Rehabilitation Medicine 2022;():21065-
Patients with severe coronavirus disease 2019 (COVID-19) have poor prognosis, with many cases being difficult to treat and many reports of neurological complications in patients who have been in the intensive care unit for a long time. Rehabilitation of patients with severe COVID-19 is important;however, no rehabilitation program has shown effectiveness. Thus, this study aimed to investigate the effects of a rehabilitation program developed and used at our hospital for patients with severe COVID-19. We enrolled 28 patients with severe COVID-19 (age 61[23-88]years;female/male, 9/19, body mass index, 25.0[18.0-33.6]kg/m2). We assessed the medical research council scoring (MRC) of the patients at the time of entry and exit from the ordinary ward using Wilcoxon signed-rank tests. MRC was significantly improved after exiting the ordinary ward compared with that on entering the ordinary ward (43 vs. 50 points;P<.001). Moreover, Barthel index improved significantly after exiting the ordinary (32.5 vs. 77.5 points, P<.001). Therefore, our acute rehabilitation treatment for patients with severe COVID-19 may be effective in improving their muscle strength and daily living.
3.Cervical dystonia in Parkinson’s disease: Retrospective study of later-stage clinical features
Hiroshi Kida ; Shiroh Miura ; Yoshihiro Yamanishi ; Tomoyuki Takahashi ; Takashi Kamada ; Akiko Yorita ; Mitsuyoshi Ayabe ; Hideki Kida ; Tomoaki Hoshino ; Takayuki Taniwaki
Neurology Asia 2018;23(3):245-251
Objective: Cervical dystonia (CD) is a clinically under-recognized symptom occurring at the later- to
end-stages of Parkinson’s disease (PD). The frequency of CD and its influence on prognosis have
not been well studied. Here, we conducted an in-depth examination of CD incidence and impact on
disease progression in later-stage PD. Methods: We retrospectively reviewed the clinical features of 22
deceased patients with sporadic PD treated at a hospital in Japan from 1983 to 2008. Results: The most
common cause of death in PD was pneumonia. CD, in particular retrocollis, was frequent in the later
stages of the disease in elderly patients (9/22, 40.9%). Pneumonia incidence increased sharply in the
later period with CD. There was a positive trend between CD duration and duration of pergolide use.
Conclusion: Analysis revealed that CD increases markedly in late- to end-stage PD, which may be
associated with aspiration pneumonia due to dysphagia. Pathological mechanisms underlying CD might
be influenced by treatments including dopamine agonists. Prevention of CD may increase quality of
life and prolong survival of PD patients.